These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 7047002

  • 1. Corticosteroid-induced osteopenia and vitamin D metabolism. Effect of vitamin D2, calcium phosphate and sodium fluoride administration.
    Rickers H, Deding A, Christiansen C, Rødbro P, Naestoft J.
    Clin Endocrinol (Oxf); 1982 Apr; 16(4):409-15. PubMed ID: 7047002
    [Abstract] [Full Text] [Related]

  • 2. Mineral loss in cortical and trabecular bone during high-dose prednisone treatment.
    Rickers H, Deding A, Christiansen C, Rødbro P.
    Calcif Tissue Int; 1984 May; 36(3):269-73. PubMed ID: 6432291
    [Abstract] [Full Text] [Related]

  • 3. [Treatment with sodium fluoride, calcium phosphate and vitamin D2 in spinal osteoporosis. Effect on calcium balance, calcium metabolism, bone remodelling, and side effects].
    Mosekilde L, Charles P, Eriksen EF, Hasling C, Melsen F.
    Ugeskr Laeger; 1986 Dec 15; 148(51):3449-53. PubMed ID: 3492800
    [No Abstract] [Full Text] [Related]

  • 4. The effects of high-dose glucocorticoid administration on serum bone gamma carboxyglutamic acid-containing protein, serum alkaline phosphatase and vitamin D metabolites in normal subjects.
    Nielsen HK, Thomsen K, Eriksen EF, Charles P, Storm T, Mosekilde L.
    Bone Miner; 1988 Apr 15; 4(1):105-13. PubMed ID: 3263890
    [Abstract] [Full Text] [Related]

  • 5. Marked decrease in trabecular bone quality after five years of sodium fluoride therapy--assessed by biomechanical testing of iliac crest bone biopsies in osteoporotic patients.
    Søgaard CH, Mosekilde L, Richards A, Mosekilde L.
    Bone; 1994 Apr 15; 15(4):393-9. PubMed ID: 7917577
    [Abstract] [Full Text] [Related]

  • 6. [Histological effects of the treatment of osteoporosis with the combination of sodium fluoride, vitamin D and calcium].
    Briançon D, Charhon S, Edouard C, Meunier PJ.
    Rev Rhum Mal Osteoartic; 1980 Dec 15; 47(12):693-8. PubMed ID: 7006045
    [Abstract] [Full Text] [Related]

  • 7. Fluoride salts are no better at preventing new vertebral fractures than calcium-vitamin D in postmenopausal osteoporosis: the FAVOStudy.
    Meunier PJ, Sebert JL, Reginster JY, Briancon D, Appelboom T, Netter P, Loeb G, Rouillon A, Barry S, Evreux JC, Avouac B, Marchandise X.
    Osteoporos Int; 1998 Dec 15; 8(1):4-12. PubMed ID: 9692071
    [Abstract] [Full Text] [Related]

  • 8. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov 15; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 9. Effect of sodium fluoride, calcium carbonate, and vitamin D on the skeleton in multiple myeloma.
    Kyle RA, Jowsey J.
    Cancer; 1980 Apr 01; 45(7):1669-74. PubMed ID: 6989479
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Treatment with high-dose oral vitamin D2 in patients with jejunoileal bypass for morbid obesity. Effects on calcium and magnesium metabolism, vitamin D metabolites, and faecal lag time.
    Charles P, Mosekilde L, Søndergård K, Jensen FT.
    Scand J Gastroenterol; 1984 Nov 01; 19(8):1031-8. PubMed ID: 6335925
    [Abstract] [Full Text] [Related]

  • 12. Influence of blanketing and season on vitamin D and parathyroid hormone, calcium, phosphorus, and magnesium concentrations in horses in New Zealand.
    Azarpeykan S, Dittmer KE, Gee EK, Marshall JC, Wallace J, Elder P, Acke E, Thompson KG.
    Domest Anim Endocrinol; 2016 Jul 01; 56():75-84. PubMed ID: 27131337
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Vitamin D metabolites in serum from hypoparathyroid patients treated with vitamin D2 and 1 alpha-hydroxyvitamin D3.
    Aksnes L, Aarskog D.
    J Clin Endocrinol Metab; 1980 Oct 01; 51(4):823-9. PubMed ID: 6968318
    [Abstract] [Full Text] [Related]

  • 16. Serum concentration of vitamin D metabolites during treatment with vitamin D2 and D3 in normal premenopausal women.
    Tjellesen L, Hummer L, Christiansen C, Rødbro P.
    Bone Miner; 1986 Oct 01; 1(5):407-13. PubMed ID: 2849489
    [Abstract] [Full Text] [Related]

  • 17. Sodium fluoride in the treatment of osteoporosis.
    Williams CC.
    Clin Invest Med; 1982 Oct 01; 5(2-3):195-7. PubMed ID: 6981483
    [No Abstract] [Full Text] [Related]

  • 18. Multiple-myeloma bone disease. The comparative effect of sodium fluoride and calcium carbonate or placebo.
    Kyle RA, Jowsey J, Kelly PJ, Taves DR.
    N Engl J Med; 1975 Dec 25; 293(26):1334-8. PubMed ID: 1102987
    [Abstract] [Full Text] [Related]

  • 19. Safe and effective treatment of osteoporosis with intermittent slow release sodium fluoride: augmentation of vertebral bone mass and inhibition of fractures.
    Pak CY, Sakhaee K, Zerwekh JE, Parcel C, Peterson R, Johnson K.
    J Clin Endocrinol Metab; 1989 Jan 25; 68(1):150-9. PubMed ID: 2909549
    [Abstract] [Full Text] [Related]

  • 20. Safety of osteoporosis treatment with sodium fluoride, calcium phosphate and vitamin D.
    Hasling C, Nielsen HE, Melsen F, Mosekilde L.
    Miner Electrolyte Metab; 1987 Jan 25; 13(2):96-103. PubMed ID: 3696093
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.